Masahiko Matsuo

Effects of FK228, a novel histone deacetylase inhibitor, on human lymphoma U-937 cells in vitro and in vivo

Yuka Sasakawa, Yoshinori Naoe, Takeshi Inoue et al. · Biochemical Pharmacology · 2002 · 94 citations

Tumor Biology, Lymphoid Neoplasia, Medicine +6

Antitumor efficacy of FK228, a novel histone deacetylase inhibitor, depends on the effect on expression of angiogenesis factors

Yuka Sasakawa, Yoshinori Naoe, Takahisa Noto et al. · Biochemical Pharmacology · 2003 · 77 citations · Full text

Implitapide, a Microsomal Triglyceride Transfer Protein Inhibitor, Reduces Progression of Atherosclerosis in Apolipoprotein E Knockout Mice Fed a Western-Type Diet: Involvement of the Inhibition of Postprandial Triglyceride Elevation

Koji Ueshima, Hitomi Akihisa-Umeno, Akira Nagayoshi et al. · Biological and Pharmaceutical Bulletin · 2005 · 63 citations · Full text

Apoe Ko, Reduces Progression, Metabolic Syndrome +16

LESSER REDUCTION IN BONE MINERAL DENSITY BY THE IMMUNOSUPPRESSANT, FK506, COMPARED WITH CYCLOSPORINE IN RATS

Takeshi Inoue, Ikuo Kawamura, Masahiko Matsuo et al. · Transplantation · 2000 · 60 citations

Marker genes to predict sensitivity to FK228, a histone deacetylase inhibitor

Yuka Sasakawa, Yoshinori Naoe, Naoki Sogo et al. · Biochemical Pharmacology · 2004 · 51 citations

Histone Modifications, Chromatin, Histone Deacetylase Inhibitor +12